Robaxin vs. Baclofen

See how Robaxin and Baclofen compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Robaxin and Baclofen are both muscle relaxants, but Robaxin is approved for short-term acute muscle spasm while Baclofen is approved for spasticity from MS or spinal cord injury.

  • Baclofen requires a gradual taper because stopping it abruptly can cause seizures or rebound spasticity, while Robaxin carries no such withdrawal risk.

  • Robaxin is not a controlled substance and comes in oral and injectable forms, while Baclofen offers more formulations plus an intrathecal pump for severe spasticity.

Robaxin vs. Baclofen Drug Summary

Robaxin

Robaxin (methocarbamol) is a centrally-acting skeletal muscle relaxant used short-term for acute, painful musculoskeletal conditions, usually alongside rest and physical therapy. It comes as an oral tablet and also as an IV/IM injection used as adjunct therapy in tetanus. Robaxin is not a controlled substance and has been used since 1957.

Baclofen

Baclofen is a GABA-B receptor agonist used to control spasticity from multiple sclerosis, spinal cord injury, or other spinal cord disease. It is taken orally several times a day, with a severe-spasticity intrathecal pump version available for cases that do not respond to oral therapy. Baclofen has been used since 1977 and comes in tablet, solution, suspension, and granule forms.

Robaxin vs. Baclofen Side Effects

Robaxin

Most common
drowsiness (rate not specified in labeling)
nausea (rate not specified in labeling)
dizziness or lightheadedness (rate not specified in labeling)
headache (rate not specified in labeling)

Baclofen

Most common
drowsiness (up to 63%)
nausea (4 to 12%)
dizziness (up to 15%)
weakness (up to 15%)

Robaxin vs. Baclofen Dosage

Robaxin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1500 mg four times daily Days 1-3
Maximum dose 1000 mg IM/IV per dose If needed
Dose changes 2 increases Every 3 days

Baclofen

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg three times daily Days 1-3
Maximum dose 20 mg four times daily If needed
Dose changes 4 increases Every 3 days

Robaxin vs. Baclofen Indications

Robaxin

Robaxin is FDA-approved as an adjunct to rest and physical therapy for the discomfort of acute, painful musculoskeletal conditions. The injectable form is also used as adjunctive therapy in tetanus. It is intended for short-term use, not long-term pain management.

  • Short-term relief of acute muscle spasm and pain

  • Used alongside rest and physical therapy

  • Injectable form used as adjunct in tetanus treatment

  • Not approved for chronic pain or long-term use

  • Not approved for children under 16

Baclofen

Baclofen is FDA-approved to treat spasticity caused by multiple sclerosis or by spinal cord injury and disease. Severe, treatment-resistant spasticity can be managed with an intrathecal pump that delivers baclofen directly to the spinal fluid. It is also used off-label for alcohol cravings, hiccups, and reflux.

  • Treats spasticity from multiple sclerosis

  • Treats spasticity from spinal cord injury or disease

  • Severe spasticity treated via intrathecal pump

  • Off-label use for alcohol cravings, hiccups, or GERD

  • Not approved for stroke, cerebral palsy, or Parkinson's spasticity

Robaxin vs. Baclofen Pros and Cons

Robaxin

Robaxin offers a straightforward option for short-term muscle spasm relief without the controlled-substance status carried by some other muscle relaxants. It is available in both oral and injectable forms, giving flexibility for acute care settings. Its label describes side effects qualitatively rather than with specific percentages.

Pros

  • Not a federally controlled substance

  • Available in oral and IV/IM injectable forms

  • No dangerous withdrawal syndrome if stopped abruptly

  • Long history of use since 1957

Cons

  • Not approved for spasticity from MS or spinal cord injury

  • Not approved for chronic or long-term pain

  • Side effect rates not quantified in labeling

  • Not approved for children under 16

Baclofen

Baclofen is the more targeted option for spasticity tied to neurological conditions like MS or spinal cord injury, with strong evidence in that population. It requires a careful taper, since stopping it abruptly can trigger serious withdrawal symptoms including seizures. Its dosing schedule is more gradual and multi-step compared to Robaxin's.

Pros

  • FDA-approved specifically for MS and spinal cord spasticity

  • Intrathecal pump option for severe, treatment-resistant cases

  • Multiple formulations (tablet, solution, granules) for flexible dosing

  • Off-label options for alcohol cravings, hiccups, and GERD

Cons

  • Requires gradual taper to avoid seizures or rebound spasticity

  • Needs dose adjustment in kidney impairment

  • Drowsiness reported in up to 63% of patients

  • Not approved for spasticity from stroke or cerebral palsy

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.